Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Zalicus Inc (NASDAQ:ZLCS) on June 18 announced that it has licensed its Sodium Channel Modulator program, including intellectual property and related pipeline assets, to AnaBios Corporation in exchange for clinical milestone payments and royalties on potential future sales. Under the terms of the agreement Zalicus will be eligible to receive up to $17.2 million in clinical and regulatory milestone payments and up to 12% of … Continue reading Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Biotech Bullish stocks: Oragenics (NYSEMKT:OGEN), Kindred Biosciences (NASDAQ:KIN), Revance Therapeutics (NASDAQ:RVNC), Stemline Therapeutics (NASDAQ:STML), Aastrom Biosciences (NASDAQ:ASTM)

On May 30, 2014 Oragenics Inc (NYSEMKT:OGEN) held its Annual meeting of Shareholders (the “Meeting”), at which Meeting, the Company’s shareholders authorized the amendment to our Amended and Restated Articles of Incorporation (the “Amendment”) to increase the number of authorized common stock to 100,000,000 shares, upon a determination by our Board of Directors that such an increase is in the best interests of our Company … Continue reading Biotech Bullish stocks: Oragenics (NYSEMKT:OGEN), Kindred Biosciences (NASDAQ:KIN), Revance Therapeutics (NASDAQ:RVNC), Stemline Therapeutics (NASDAQ:STML), Aastrom Biosciences (NASDAQ:ASTM)

Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)

Cara Therapeutics Inc (NASDAQ:CARA) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.31. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was 3.44% in last session and finished the day at $19.25. Traded volume was 234.6K shares in the last session and the average volume of the stock remained 298.33K … Continue reading Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)